BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12800340)

  • 1. Different aspects of peritoneal sclerosis.
    Garosi G
    Contrib Nephrol; 2003; (140):18-29. PubMed ID: 12800340
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of peritoneal dialysis on peritoneal morphology.
    Dobbie JW; Anderson JD; Hind C
    Perit Dial Int; 1994; 14 Suppl 3():S16-20. PubMed ID: 7948267
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?
    Diaz-Buxo JA
    Contrib Nephrol; 2003; (140):264-71. PubMed ID: 12800368
    [No Abstract]   [Full Text] [Related]  

  • 4. Normal peritoneum after nine years of peritoneal dialysis with biocompatible dialysate: a case report.
    Kamijo Y; Iida H; Saito K; Furutera R; Ishibashi Y
    Perit Dial Int; 2013; 33(6):712-4. PubMed ID: 24335133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms].
    Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B
    Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
    Pletinck A; Vanholder R; Veys N; Van Biesen W
    Nat Rev Nephrol; 2012 Sep; 8(9):542-50. PubMed ID: 22777203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers in peritoneal effluent: are they useful?
    Krediet RT
    Contrib Nephrol; 2003; (140):30-7. PubMed ID: 12800341
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.
    Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Pawlaczyk K; Kuzlan-Pawlaczyk M; Filas V; Breborowicz A; Oreopoulos DG
    Nephrol Dial Transplant; 2001 Mar; 16(3):655-6. PubMed ID: 11239060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical aspects in studying peritoneal morphology in animal models of peritoneal dialysis.
    Duman S; Sen S
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S40-4. PubMed ID: 19270229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of biocompatibility in peritoneal dialysis solutions.
    Passlick-Deetjen J
    Perit Dial Int; 1993; 13 Suppl 2():S101-4. PubMed ID: 8399540
    [No Abstract]   [Full Text] [Related]  

  • 11. Biocompatibility of peritoneal dialysis treatment.
    Di Paolo N; Garosi G; Monaci G; Brardi S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():78-83. PubMed ID: 9075235
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Surgical management of peritoneal dialysis peritonitis: the impact of peritoneal sclerosis.
    Mavor E
    World J Surg; 2009 Jul; 33(7):1395. PubMed ID: 19404707
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
    Mortier S; De Vriese AS; Lameire N
    Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
    Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis.
    Garosi G; Di Paolo N
    Adv Perit Dial; 2000; 16():204-7. PubMed ID: 11045294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninfectious causes of cloudy peritoneal dialysate.
    Rocklin MA; Teitelbaum I
    Semin Dial; 2001; 14(1):37-40. PubMed ID: 11208038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecology of the peritoneum: a substantial role for the osmotic agents resulting in apoptosis of mesothelial cells.
    Gotloib L; Wajsbrot V; Shostak A
    Contrib Nephrol; 2003; (140):10-7. PubMed ID: 12800339
    [No Abstract]   [Full Text] [Related]  

  • 20. Taming apoptosis in peritoneal dialysis.
    Santamaria B; Ucero AC; Benito-Martin A; Selgas R; Ruiz-Ortega M; Sanz AB; Egido J; Ortiz A
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S45-8. PubMed ID: 19270230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.